期刊文献+

miR-125a表达对肝癌HepG2细胞增殖、凋亡及细胞周期的影响分析 被引量:3

Influence of miR-125a on the proliferation,apoptosis and cell cycle of human hepatoma Hep G2 cells
下载PDF
导出
摘要 目的探讨microRNA-125a(miR-125a)对肝癌Hep G2细胞增殖、凋亡及细胞周期的影响。方法采用实时荧光定量PCR(q PCR)法检测人肝癌Hep G2细胞及人正常肝细胞7702中的miR-125a水平,同时采用真核表达载体p Genesil-1质粒制备过表达miR-125a的重组质粒p Genesil-miR-125a及表达随机序列的阴性对照p Genesil-NC,根据实验设计将Hep G2细胞分为3组:空白对照组、阴性对照组和过表达组,其中空白对照组未进行转染,阴性对照组和过表达组分别成功转染p Genesil-NC和p Genesil-miR-125a,待3组转染24、48、72及96 h后采用q PCR法检测各组的miR-125a水平,噻唑盐比色法检测各组转染24、48、72及96 h的细胞增殖率,分别采用Hoechst染色和流式细胞术检测转染24、48 h后的凋亡指数和caspase-3活化率来评价凋亡情况,流式细胞仪Annexin V-FITC/PI双染流式细胞术检测各组转染48 h后的细胞周期,同时采用免疫印迹法检测转染48 h后对凋亡相关基因(Bcl-2、Bax和Cleaved caspase-3)表达的影响。结果 Hep G2细胞中miR-125a水平为(0.24±0.06),低于正常肝细胞7702细胞(P<0.05);与阴性表达组相比,过表达组转染24、48、72及96 h的miR-125a水平升高,增殖率降低,差异有统计学意义(P<0.05);与其余两组相比,过表达组转染后的凋亡指数、caspase-3活化率、G0/G1期细胞比例及Bax和Cleaved caspase-3水平均升高,S和G2/M期细胞比例及Bcl-2水平均降低,以上差异有统计学意义(P<0.05)。结论肝癌Hep G2细胞中miR-125a低表达,且过表达miR-125a可抑制增殖、诱导凋亡及G0/G1期细胞阻滞,在肝癌的发生发展中可能起到抑癌基因的作用。 Objective To explore the influence of microRNA-125a( miR-125a) on the proliferation,apoptosis and cell cycle of human hepatoma Hep G2 cells. Methods The real-time fluorescence quantitative PCR( q PCR) was employed to measure the miR-125 a level in human hepatocellular carcinoma Hep G2 cell and normal liver 7702 cells. The eukaryotic expression plasmid vector p Genesil-1 was used to construct recombinant plasmid p Genesil-miR-125 a. Meanwhile,a control plasmid p Genesil-control with random sequence was constructed. According to the experimental design,the Hep G2 cells were divided into 3 groups: blank control group( Hep G2 cells without transfection),negative control group( Hep G2 cells transfected with p Genesil-NC) and over-expression group( Hep G2 cells transfected with p Genesil-miR-125a). The q PCR was used to investigate the miR-125 a level of three groups at 24,48,72 and 96 h after transfection. Tetrazolium salt( MTT) colorimetric assay was used to assess the proliferative responses of Hep G2 at 24,48,72 and 96 h after transfection. The Hoechst staining and flow cytometry were used to evaluate the apoptosis index and caspase-3activation rate to evaluate the apoptosis at 24 and 48 h after transfection. The cell cycle at 48 h after transfection was determined by Annexin V-FITC / PI double staining with the use of flow cytometry analysis. Western blotting was employed to analyze the protein levels of apoptosis related genes( Bcl-2,Bax and Cleaved caspase-3) at 48 h after transfection. Results The level of miR-125 a in Hep G2 cell was( 0. 24 ± 0. 06),lower than that of 7702 cell( P〈0. 05). MiR-125 a level increased but proliferation rate decreased at 24,48,72 and96 h after transfection in over-expression group versus negative control group with statistically significant difference( P〈0. 05). In contrast to other two groups,there were elevated apoptosis index,caspase-3 activation rate,percentage of G0/ G1 and protein level of Bax and Cleaved caspase-3 but decreased percentage of S and G2/ M phase and protein level of Bcl-2 with statistically significant difference( P〈0. 05). Conclusion There is low expression of miR-125 a in Hep G2 cells,and the over-expression of miR-125 a can inhibit the proliferation,induce cell apoptosis and G0/ G1 arrest,playing as tumor suppressor gene in the development of hepatocellular carcinoma.
机构地区 解放军
出处 《临床肿瘤学杂志》 CAS 2015年第1期8-12,共5页 Chinese Clinical Oncology
关键词 microRNA-125a 肝癌 增殖 凋亡 细胞周期 MicroRNA-125a Hepatocellular carcinoma Proliferation Apoptosis Cell cycle
  • 相关文献

参考文献11

  • 1Song P, Feng X, Zhang K, et al. Screening for and surveillance of high-risk patients with HBV-related chronic liver disease: pro- moting the early detection of hepatoce|lular carcinoma in China [J]. Biosci Trends, 2013, 7(1) :1-6.
  • 2Hoshida Y, Moeini A, Alsinet C, et al. Gene signatures in the management of hepatocellular carcinoma [ J ]. Semin Oncol, 2012, 39(4) :473-485.
  • 3Jin Z, Selaru FM, Cheng Y, et al. MicroRNA-192 and-215 are upregulated in human gastric cancer in vivo and suppress ALCAM expression in vitro[ J ]. Oneogene, 2011, 30(13) : 1577-1585.
  • 4Bi Q,Tang S,Xia L, et al.Ectopic expression of miR-125a inhibits the proliferation and metastasis of hepatoeellular carcinoma by tar- geting MMPll and VEGF [ J/OL]. PLoS One, 2012, 7 (6) [ 2014-06-07 ]. http://www, ncbi. nlm. nih. gov/pmc/articles/ pmid/22768249.
  • 5胡金华,吴玉泉,陈清勇,赵园园,焦德敏.上调miR-125a对肺癌A549细胞凋亡的影响及其机制研究[J].临床肿瘤学杂志,2013,18(3):199-202. 被引量:2
  • 6Huang F, Tang J, Zhuang X, et al. MiR-196a promotes pancre- atic cancer progression by targeting nuclear factor kappa-B-inhibi- tor alpha [ J/OL ]. PLoS One, 2014, 9 (2) [ 2014-09-15 ]. http ://www. ncbi.nlm.nih.gov/pmc/articles/pmid/24504166.
  • 7胡欣春,魏益平,喻东亮,彭金华,徐建军.miR-21抑制物对A549细胞球增殖的影响及机制[J].中国老年学杂志,2014,34(9):2456-2459. 被引量:3
  • 8Zheng T, Wang J, Chen X, et al. Role of microRNA in antican- cer drug resistance[J]. Int J Cancer, 2010, 126( 1 ) : 2-10.
  • 9Utkin ML, Peterson S, Yang X, et al. miR-125a regulates cell cycle, proliferation, and apoptosis by targeting the ErbB pathway in acute myeloid leukemia [ J ]. Leuk Res, 2014, 38 ( 3 ) : 402 -410.
  • 10Jiang L, Chang J, Zhang Q, et al. MicroRNA hsa-miR-125a-3p activates p53 and induces apoptosis in lung cancer cells [ J ]. Cancer Invest, 2013, 31 (8) : 538- 544.

二级参考文献5

共引文献3

同被引文献36

  • 1Jemal A, Siegel R, Xu J, et al. Cancer statistics, 2010[J]. CA Cancer J Clin, 2010, 60(5) :277-300.
  • 2Koh WJ, Greer BE, Abu-Rustum NR, et al. Cervical Cancer, Version 2. 2015 [ J 1. J Natl Compr Canc Netw, 2015, 13 (4) : 395-404.
  • 3Bai D, Zhang J, Xiao W, et al. Regulation of the HDM2-p53 pathway by ribosomal protein L6 in response to ribosomal stress [ J ]. Nucleic Acids Res, 2014, 42 (3) : 1799-1811.
  • 4Wu Q, Gou Y, Wang Q, et al. Downregulation of RPL6 by siR- NA inhibits proliferation and cell cycle progression of human gas- tric cancer cell lines [ J/OL:. PLoS One, 2011 [ 2015-06-201 .ht-tp ://www. ncbi. nlm. nih.gov/pubmed/22043320.122-132.
  • 5Wang R, Yoshida K, Toki T, et al. Loss of function mutations in RPL27 and RPS27 identified by whole-exome sequencing in Dia- mond-Blaekfan anaemia[ J:. Br J Haematol, 2015, 168(6) :854 -864.
  • 6Ye Q, Ding SF, Wang ZA, et al. Influence of ribosomal protein L39-L in the drug resistance mechanisms of lacrimal gland adenoid cystic carcinoma ceils [ J ]. Asian Pac J Cancer Prev, 2014, 15(12) :4995-5000.
  • 7Liu HS, Tan WB, Yang N, et al. Effects of ribosomal protein 139-L on the drug resistance mechanisms of lung cancer A549 cells [ J ]. Asian Pae J Cancer Prey, 2014, 15 (7) : 3093 - 3097.
  • 8Wang Q, Yang C, Zhou J, et al. Cloning and characterization of full-length human ribosomal protein L15 eDNA which wa: overex- pressed in esophageal cancer[ J:. Gene, 2001, 263 (1-2) :205 - 209.
  • 9Yi YW, You K, Bae EJ, et al. Dual inhibition of EGFR and MET induces synthetic lethality in triple-negative breast cancer ceils through downregulation of ribosomal protein $6 [ Jl. Int J Oncol, 2015,47( 1 ) : 122-132.
  • 10Du J, Shi Y, Pan Y, et al. Regulation of muhidrug resistance byribosomal protein 16 in gastric cancer cells [ J 1. Cancer Biol Ther, 2005, 4(2) :242-247.

引证文献3

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部